Digital health revolution: perfect storm or perfect opportunity for pharmaceutical R&D?
暂无分享,去创建一个
[1] K. Servick. Mind the phone. , 2015, Science.
[2] Elizabeth Gibney,et al. The inside story on wearable electronics , 2015, Nature.
[3] Michael Eisenstein. GSK collaborates with Apple on ResearchKit , 2015, Nature Biotechnology.
[4] Kat Austen,et al. What could derail the wearables revolution? , 2015, Nature.
[5] Daphne Zohar,et al. Building a business model in digital medicine , 2015, Nature Biotechnology.
[6] Joshua C. Mandel,et al. Driving Innovation in Health Systems through an Apps-Based Information Economy. , 2015, Cell systems.
[7] Konrad Paul Kording,et al. Mobile Phone Sensor Correlates of Depressive Symptom Severity in Daily-Life Behavior: An Exploratory Study , 2015, Journal of medical Internet research.
[8] N. Sharma. Patient centric approach for clinical trials: Current trend and new opportunities , 2015, Perspectives in clinical research.
[9] E. Elenko,et al. A regulatory framework emerges for digital medicine , 2015, Nature Biotechnology.
[10] William Stafford Noble,et al. Machine learning applications in genetics and genomics , 2015, Nature Reviews Genetics.
[11] Max A. Little,et al. Detecting and monitoring the symptoms of Parkinson's disease using smartphones: A pilot study. , 2015, Parkinsonism & related disorders.
[12] Mumbai,et al. Internet of Things (IoT): A Literature Review , 2015 .
[13] Stefan Kopp,et al. Exploring the Alignment Space – Lexical and Gestural Alignment with Real and Virtual Humans , 2015, Front. ICT.
[14] Brian W. Powers,et al. The digital phenotype , 2015, Nature Biotechnology.
[15] Eric Elenko,et al. Defining digital medicine , 2015, Nature Biotechnology.
[16] D. Laws. What Value Does the Pharmaceutical Industry Bring to Health Care? , 2015 .
[17] Jesse Dallery,et al. A New Frontier: Integrating Behavioral and Digital Technology to Promote Health Behavior , 2014, The Behavior Analyst.
[18] Denzil A. Harris,et al. Novel methods and technologies for 21st-century clinical trials: a review. , 2015, JAMA neurology.
[19] N. Schork. Personalized medicine: Time for one-person trials , 2015, Nature.
[20] Markus Reichert,et al. Improving Motor Activity Assessment in Depression: Which Sensor Placement, Analytic Strategy and Diurnal Time Frame Are Most Powerful in Distinguishing Patients from Controls and Monitoring Treatment Effects , 2015, PloS one.
[21] John Crowe,et al. Objective Methods for Reliable Detection of Concealed Depression , 2015, Front. ICT.
[22] Nigel H. Lovell,et al. Low-power technologies for wearable telecare and telehealth systems: A review , 2015 .
[23] E. Chiauzzi,et al. Patient-centered activity monitoring in the self-management of chronic health conditions , 2015, BMC Medicine.
[24] E. Chiauzzi,et al. Remote Tracking of Walking Activity in MS Patients in a Real-World Setting (P3.209) , 2015 .
[25] Y. Scherer,et al. Effects of Using Nintendo Wii™ Exergames in Older Adults , 2015, Journal of aging and health.
[26] C. Lavie,et al. Health care 2020: reengineering health care delivery to combat chronic disease. , 2015, The American journal of medicine.
[27] R. Brian Haynes,et al. Technology-mediated interventions for enhancing medication adherence , 2015, J. Am. Medical Informatics Assoc..
[28] D. Rothenbacher,et al. New opportunities of real-world data from clinical routine settings in life-cycle management of drugs: example of an integrative approach in multiple sclerosis , 2015, Current medical research and opinion.
[29] S. Papapetropoulos,et al. Digital Health Revolution: Is it Time for Affordable Remote Monitoring for Parkinson’s Disease? , 2015, Front. Neurol..
[30] F. Collins,et al. A new initiative on precision medicine. , 2015, The New England journal of medicine.
[31] Tom Chau,et al. E-textiles in Clinical Rehabilitation: A Scoping Review , 2015 .
[32] Vijay S. Pande,et al. Massively Multitask Networks for Drug Discovery , 2015, ArXiv.
[33] Brian Scassellati,et al. Integrating socially assistive robotics into mental healthcare interventions: applications and recommendations for expanded use. , 2015, Clinical Psychology Review.
[34] Naomi Lee. The Lancet Technology: January, 2015 , 2015, The Lancet.
[35] Colleen Cheek,et al. Serious games for the treatment or prevention of depression: A systematic review , 2015 .
[36] S. Horton,et al. Effectiveness of commercial video gaming on fine motor control in chronic stroke within community-level rehabilitation , 2015, Disability and rehabilitation.
[37] Beyond the pill: The move towards value-added services in the pharmaceutical industry: , 2014 .
[38] H. L. Horne-Moyer,et al. The Use of Electronic Games in Therapy: a Review with Clinical Implications , 2014, Current Psychiatry Reports.
[39] D. Mccarthy,et al. A Vision for Using Digital Health Technologies to Empower Consumers and Transform the U.S. Health Care System , 2014 .
[40] Jean-Yves Reginster,et al. The quantified patient: a patient participatory culture , 2014, Current medical research and opinion.
[41] Aaron S Kesselheim,et al. FDA regulation of mobile health technologies. , 2014, The New England journal of medicine.
[42] P. Briss,et al. Prevention of chronic disease in the 21st century: elimination of the leading preventable causes of premature death and disability in the USA , 2014, The Lancet.
[43] Bruce A. MacDonald,et al. The Role of Healthcare Robots for Older People at Home: A Review , 2014, Int. J. Soc. Robotics.
[44] S. Cummings,et al. Web-based trial to evaluate the efficacy and safety of tolterodine ER 4 mg in participants with overactive bladder: REMOTE trial. , 2014, Contemporary clinical trials.
[45] J. Bardram,et al. Smartphone data as objective measures of bipolar disorder symptoms , 2014, Psychiatry Research.
[46] D. Heldman,et al. Clinician versus machine: reliability and responsiveness of motor endpoints in Parkinson's disease. , 2014, Parkinsonism & related disorders.
[47] P. Wicks. Could digital patient communities be the launch pad for patient-centric trial design? , 2014, Trials.
[48] Carmen C. Y. Poon,et al. Unobtrusive Sensing and Wearable Devices for Health Informatics , 2014, IEEE Transactions on Biomedical Engineering.
[49] W. Wayt Gibbs. Medicine gets up close and personal , 2014, Nature.
[50] Shane A Lowe,et al. Monitoring human health behaviour in one's living environment: a technological review. , 2014, Medical engineering & physics.
[51] W. Riedel. Preventing cognitive decline in preclinical Alzheimer's disease. , 2014, Current opinion in pharmacology.
[52] Nita A. Farahany,et al. Regulation: The FDA is overcautious on consumer genomics , 2014, Nature.
[53] David Feeny,et al. Framework to assess the effects of using patient-reported outcome measures in chronic care management , 2014, Quality of Life Research.
[54] H. Dawes,et al. Wearable accelerometry-based technology capable of assessing functional activities in neurological populations in community settings: a systematic review , 2014, Journal of NeuroEngineering and Rehabilitation.
[55] Sean W. Smith,et al. Securing Information Technology in Healthcare , 2013, IEEE Security & Privacy.
[56] B. Bloem,et al. Quantitative wearable sensors for objective assessment of Parkinson's disease , 2013, Movement disorders : official journal of the Movement Disorder Society.
[57] Camarin E. Rolle,et al. Video game training enhances cognitive control in older adults , 2013, Nature.
[58] V. Marx. Biology: The big challenges of big data , 2013, Nature.
[59] M. J. Brooke,et al. Food and Drug Administration Regulation of Diabetes-Related mHealth Technologies , 2013, Journal of diabetes science and technology.
[60] Maria Wolters,et al. Activity monitoring in patients with depression: a systematic review. , 2013, Journal of affective disorders.
[61] Jean-Yves Fourniols,et al. Smart wearable systems: Current status and future challenges , 2012, Artif. Intell. Medicine.
[62] L. Hood,et al. A personal view on systems medicine and the emergence of proactive P4 medicine: predictive, preventive, personalized and participatory. , 2012, New biotechnology.
[63] R. Stafford,et al. From sick care to health care--reengineering prevention into the U.S. system. , 2012, The New England journal of medicine.
[64] Dae-Hyeong Kim,et al. Flexible and stretchable electronics for biointegrated devices. , 2012, Annual review of biomedical engineering.
[65] Takanori Shibata,et al. Therapeutic Seal Robot as Biofeedback Medical Device: Qualitative and Quantitative Evaluations of Robot Therapy in Dementia Care , 2012, Proceedings of the IEEE.
[66] W. Oertel,et al. Identifying prodromal Parkinson's disease: Pre‐Motor disorders in Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.
[67] D. Berwick,et al. Eliminating waste in US health care. , 2012, JAMA.
[68] G. Clifford,et al. Wireless technology in disease management and medicine. , 2012, Annual review of medicine.
[69] H. Kitano,et al. Software for systems biology: from tools to integrated platforms , 2011, Nature Reviews Genetics.
[70] M. Kenward,et al. Smoking cessation support delivered via mobile phone text messaging (txt2stop): a single-blind, randomised trial , 2011, The Lancet.
[71] T. Shibata,et al. Robot Therapy: A New Approach for Mental Healthcare of the Elderly – A Mini-Review , 2010, Gerontology.
[72] Alex S. Taylor,et al. Machine intelligence , 2009, CHI.
[73] Jeremy Ginsberg,et al. Detecting influenza epidemics using search engine query data , 2009, Nature.
[74] J. Jankovic,et al. Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results , 2008, Movement disorders : official journal of the Movement Disorder Society.
[75] D. Lauffenburger,et al. Physicochemical modelling of cell signalling pathways , 2006, Nature Cell Biology.
[76] J. Castle,et al. An integrative genomics approach to infer causal associations between gene expression and disease , 2005, Nature Genetics.
[77] Robert O. Becker,et al. The Body Electric , 1985 .
[78] R. Dawkins,et al. The extended phenotype : the gene as the unit of selection , 1982 .
[79] P. Mcgeer,et al. DERANGED PURINE METABOLISM MANIFESTED BY ANINOIMIDAZOLECARBOXAMIDE EXCRETION IN MEGALOBLASTIC ANAEMIAS, HAEMOLYTIC ANAEMIA, AND LIVER DISEASE. , 1964, Lancet.